An innovative, simple, fast, and less toxic high-performance liquid chromatographic method for determination of prednisone in capsules

Authors

  • Pedro Henrique Reis da Silva Federal University of Minas Gerais; Faculty of Pharmacy; Department of Pharmaceutical Products
  • Paula Cristina Rezende Enéas Oswaldo Cruz Foundation; René Rachou Research Center
  • Christian Fernandes Federal University of Minas Gerais; Faculty of Pharmacy; Department of Pharmaceutical Products
  • Gerson Antônio Pianetti Federal University of Minas Gerais; Faculty of Pharmacy; Department of Pharmaceutical Products

DOI:

https://doi.org/10.1590/s2175-97902017000216064

Keywords:

Prednisone, Capsules, High performance liquid chromatography/validation, Linearity assessment.

Abstract

Prednisone is an anti-inflammatory steroid drug widely used in clinical practice. However, no high-performance liquid chromatographic (HPLC) method has been described in the literature for the determination of prednisone in capsules until now. Thus, an HPLC method was developed using a C18 (250x4.0, 5 µm) column, with methanol:water (70:30) as mobile phase at a flow rate of 1 mL/min and detection at 240 nm. The developed method was validated following current Brazilian legislation. Additionally, linearity was assessed by evaluating the assumptions of normality, homoscedasticity, and independency of residuals, and the fit to the linear model. The method showed linearity (r2>;0.99) over the range of 14.0-26.0 µg/mL, selectivity, precision (RSD<2.0%), robustness, and accuracy (average recovery of 100.05%). The chromatographic procedure was applied for assay and uniformity content determination of three different batches of prednisone capsules, showing to be suitable for their quality control.

Downloads

Download data is not yet available.

Downloads

Published

2017-01-01

Issue

Section

Articles

How to Cite

An innovative, simple, fast, and less toxic high-performance liquid chromatographic method for determination of prednisone in capsules. (2017). Brazilian Journal of Pharmaceutical Sciences, 53(2), e16064-. https://doi.org/10.1590/s2175-97902017000216064